SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-201740
Filing Date
2023-08-02
Accepted
2023-08-02 16:19:34
Documents
5
Effectiveness Date
2023-08-02

Document Format Files

Seq Description Document Type Size
1 S-8 d515034ds8.htm S-8 40373
2 EX-5.1 d515034dex51.htm EX-5.1 5636
3 EX-23.2 d515034dex232.htm EX-23.2 1643
4 EX-FILING FEES d515034dexfilingfees.htm EX-FILING FEES 17406
5 GRAPHIC g515034g0802102602920.jpg GRAPHIC 2675
  Complete submission text file 0001193125-23-201740.txt   70204
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273608 | Film No.: 231135931
SIC: 2834 Pharmaceutical Preparations